NJ State Employees Deferred Compensation Plan - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 164 filers reported holding CLOVIS ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
NJ State Employees Deferred Compensation Plan ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$15,000
-34.8%
13,0000.0%0.00%
-25.0%
Q2 2022$23,000
-11.5%
13,0000.0%0.00%0.0%
Q1 2022$26,000
-25.7%
13,0000.0%0.00%0.0%
Q4 2021$35,000
-39.7%
13,0000.0%0.00%
-50.0%
Q3 2021$58,000
-22.7%
13,0000.0%0.01%
-20.0%
Q2 2021$75,000
-17.6%
13,0000.0%0.01%
-23.1%
Q1 2021$91,000
+46.8%
13,0000.0%0.01%
+30.0%
Q4 2020$62,000
-18.4%
13,0000.0%0.01%
-28.6%
Q3 2020$76,000
-13.6%
13,0000.0%0.01%
-17.6%
Q2 2020$88,000
+6.0%
13,0000.0%0.02%
-10.5%
Q1 2020$83,000
-39.0%
13,0000.0%0.02%
-17.4%
Q4 2019$136,000
+166.7%
13,0000.0%0.02%
+155.6%
Q3 2019$51,000
-73.6%
13,0000.0%0.01%
-74.3%
Q2 2019$193,000
-40.2%
13,0000.0%0.04%
-40.7%
Q1 2019$323,000
+28.7%
13,000
-7.1%
0.06%
+13.5%
Q4 2018$251,000
-38.9%
14,0000.0%0.05%
-25.7%
Q3 2018$411,000
-30.5%
14,000
+7.7%
0.07%
-34.0%
Q2 2018$591,000
+1.7%
13,000
+18.2%
0.11%
+1.9%
Q1 2018$581,000
-5.1%
11,000
+22.2%
0.10%
-1.9%
Q4 2017$612,000
-17.5%
9,0000.0%0.11%
-21.5%
Q3 2017$742,0009,0000.14%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders